Carson Wealth (CWM LLC)
EDIT icon

Carson Wealth (CWM LLC)’s Editas Medicine EDIT Stock Holding History

Carson Wealth (CWM LLC)’s Portfolio EDIT Stock Details EDIT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$259K Buy
105,001
+60,835
+138% +$129K ﹤0.01% 2502
2025
Q4 		$91K Sell
44,166
-462
-1% -$1.33K ﹤0.01% 3134
2025
Q3 		$155K Buy
44,628
+291
+0.7% +$812 ﹤0.01% 2642
2025
Q2 		$98K Sell
44,337
-2,959
-6% -$4.84K ﹤0.01% 2747
2025
Q1 		$55K Buy
47,296
+32,455
+219% +$47.7K ﹤0.01% 2898
2024
Q4 		$19K Buy
14,841
+6,839
+85% +$17.4K ﹤0.01% 3466
2024
Q3 		$27K Buy
8,002
+7,487
+1,454% +$32.6K ﹤0.01% 3171
2024
Q2 		$2K Sell
515
-27
-5% -$152 ﹤0.01% 4189
2024
Q1 		$4K Buy
542
+16
+3% +$133 ﹤0.01% 3750
2023
Q4 		$5K Buy
526
+33
+7% +$290 ﹤0.01% 3498
2023
Q3 		$4K Buy
493
+69
+16% +$592 ﹤0.01% 3549
2023
Q2 		$3K Sell
424
-98
-19% -$854 ﹤0.01% 3625
2023
Q1 		$4K Buy
522
+239
+84% +$2.13K ﹤0.01% 3375
2022
Q4 		$3K Hold
283
– – ﹤0.01% 3398
2022
Q3 		$3K Hold
283
– – ﹤0.01% 3285
2022
Q2 		$3K Sell
283
-129
-31% -$1.73K ﹤0.01% 3182
2022
Q1 		$8K Sell
412
-733
-64% -$13.6K ﹤0.01% 2608
2021
Q4 		$30K Buy
+1,145
New +$39.4K ﹤0.01% 1777
2021
Q2 		$63K Hold
1,109
– – ﹤0.01% 1303
2021
Q1 		$63K Hold
1,109
– – ﹤0.01% 1303
2020
Q4 		$63K Hold
1,109
– – ﹤0.01% 1303
2020
Q3 		$63K Hold
1,109
– – ﹤0.01% 1303
2020
Q2 		$63K Hold
1,109
– – ﹤0.01% 1303
2020
Q1 		$63K Hold
1,109
– – ﹤0.01% 1303
2019
Q4 		$63K Hold
1,109
– – ﹤0.01% 1303
2019
Q3 		$63K Hold
1,109
– – ﹤0.01% 1303
2019
Q2 		$63K Hold
1,109
– – ﹤0.01% 1303
2019
Q1 		$63K Buy
+1,109
New +$25.1K ﹤0.01% 1303

Other funds holding EDIT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Carson Wealth (CWM LLC)'s EDIT Position: Q1 2026 in Review

Carson Wealth (CWM LLC) increased its Editas Medicine (EDIT) stake by 138% in Q1 2026, buying an estimated $129K and bringing the position to 105,001 shares worth $259K. The position accounts for ﹤0.01% of the portfolio, ranked #2502.

Carson Wealth (CWM LLC) first reported a position in EDIT in Q1 2019 and has held it in 28 quarters since. 208 funds tracked by Wall St. Rank hold EDIT as of Q1 2026.

  • Carson Wealth (CWM LLC) held 105,001 shares of Editas Medicine worth $259K as of Q1 2026.
  • Carson Wealth (CWM LLC) bought 60,835 Editas Medicine shares in Q1 2026, an estimated $129K.
  • Editas Medicine made up ﹤0.01% of Carson Wealth (CWM LLC)'s portfolio in Q1 2026, its #2502 holding.
  • Carson Wealth (CWM LLC) first reported a position in Editas Medicine in Q1 2019 and has held it in 28 quarters since.
  • 208 funds tracked by Wall St. Rank held Editas Medicine as of Q1 2026.

Based on Carson Wealth (CWM LLC)'s 13F filing for Q1 2026, filed 14 May 2026.